The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cell counting market report forecasts the cell counting market size to grow to $13.04 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Cell Counting Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Cell Counting Market Size Forecast
The global cell counting market is expected to grow from $9.07 billion in 2022 to $9.76 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cell counting market size is expected to grow to $13.04 billion in 2027 at a CAGR of 7.5%.

North America held the largest cell counting market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Cell Counting Market Driver ­– Growth In Prevalence Of Cancer Amongst The Global Population
For example, according to the American Cancer Society, 1.8 million new cancer cases were diagnosed in 2020, and 606,520 cancer deaths occurred in the United States. Whereas in 2021, it has been estimated as 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the US show increasing growth in chronic diseases in the country. Therefore, the growing prevalence of cancer amongst the global population drives the growth of the cell counting market.

Request for A Sample Of The Global Cell Counting Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6489&type=smp

Key Cell Counting Market Trend – Technological Advancement
The key players operating in the cell counting market are focused on developing new technological solutions to strengthen their position in the market. The innovative solutions of next-generation information management focus on improving patient care. This discovery should increase the capabilities that can help improve efficiency within the hospital laboratory or network with the help of data visualization and analysis software. For instance, Bio-Rad Laboratories Inc., a US-based developer and manufacturer of specialized technological products for life science research and clinical diagnostics launched TC20 Automated Cell Counter, an advanced cell counter with innovative auto-focus technology and a sophisticated cell-counting algorithm. It offers accurate mammalian cell counting in less than 30 seconds.

Cell Counting Market Segment
1) By Consumables And Accessories: Media, Sera And Reagents, Assay Kits, Microplates, Accessories, Other Consumables
2) By Product: Spectrophotometers, Single-Mode Readers, Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers, Hematology Analyzers
3) By Application: Research Applications, Clinical And Diagnostic Applications, Industrial Applications
4) By End-User: Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users

Cell Counting Market Major Players and Strategies
Major players in the cell counting market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Biotek Instruments, Agilent Technologies, General Electric Company, Becton Dickinson and Company, Olympus Corporation, Horiba Ltd., Logos Biosystems Inc., Corning Incorporated, Abbott, Diconex, Beckman Coulter Inc., Nexcelom Bioscience LLC, ChemoMetec A/S, Advanced Instruments, R&D Systems Inc., and Cole-Parmer Instrument Company LLC.

In March 2020, Danaher Corporation, a US-based science & technology company, acquired the Biopharma business from General Electric Company’s Life Sciences division for an amount of $21.4 billion. With this acquisition, Danaher wants to solve complex challenges and improve the quality of life around the world. GE is a US-based conglomerate company whose Life Sciences division consists of process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and service.

The Cell Counting Global Market Report 2023 covers regional data on cell counting market size, cell counting market trends and drivers, opportunities, strategies, and cell counting market competitor analysis. The countries covered in the cell counting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cell counting refers to any of techniques used for counting cells or quantification of cells in the life sciences for diagnosis and treatment. Cell counting is used in monitoring cell health and proliferation rate assessing immortalization or transformation, transfection or infection, seeding cells for subsequent experiments, and preparing for cell-based assays.

View More Reports Related To The Cell Counting Market –
Cell Culture Consumables And Equipment Global Market Report 2023
Cell Culture Global Market Report 2023
Cell Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: